» Authors » David Sarrut

David Sarrut

Explore the profile of David Sarrut including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 73
Citations 944
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vergnaud L, Dewaraja Y, Giraudet A, Badel J, Sarrut D
EJNMMI Phys . 2024 Jul; 11(1):65. PMID: 39023648
radiopharmaceutical therapy is a standardized systemic treatment, with a typical dose of 7.4 GBq per injection, but its response varies from patient to patient. Dosimetry provides the opportunity to personalize...
2.
Salvadori J, Merlet A, Presles B, Cabello J, Su K, Cochet A, et al.
Phys Med Biol . 2024 Jul; 69(16). PMID: 39009009
. We introduce a versatile methodology for the accurate modelling of PET imaging systems via Monte Carlo simulations, using the Geant4 application for tomographic emission (GATE) platform. Accurate Monte Carlo...
3.
Claude L, Schiffler C, Isnardi V, Metzger S, Darnis S, Martel-Lafay I, et al.
Radiother Oncol . 2024 Jul; 199:110435. PMID: 39004227
Background: Locally advanced non-small cell lung cancer (LA-NSCLC) reported poor 5-year survival rates with frequent local or regional recurrences. Personalized RT may contribute to improve control and clinical outcome. We...
4.
Benzazon N, Carre A, de Kermenguy F, Niyoteka S, Maury P, Colnot J, et al.
Int J Radiat Oncol Biol Phys . 2024 Mar; 120(1):253-264. PMID: 38554830
Purpose: The dose deposited outside of the treatment field during external photon beam radiation therapy treatment, also known as out-of-field dose, is the subject of extensive study as it may...
5.
Salvadori J, Allegrini O, Opsommer T, Carullo J, Sarrut D, Porot C, et al.
EJNMMI Phys . 2024 Feb; 11(1):15. PMID: 38316677
Background: In peptide receptor radionuclide therapy (PRRT), accurate quantification of kidney activity on post-treatment SPECT images paves the way for patient-specific treatment. Due to the limited spatial resolution of SPECT...
6.
Di Franco F, Baudier T, Pialat P, Munoz A, Martinon M, Pommier P, et al.
Phys Med . 2024 Jan; 118:103207. PMID: 38215607
Purpose: To retrospectively assess the differences between planned and delivered dose during ultra-hypofractionated (UHF) prostate cancer treatments, by evaluating the dosimetric impact of daily anatomical variations alone, and in combination...
7.
Vergnaud L, Badel J, Giraudet A, Kryza D, Mognetti T, Baudier T, et al.
EJNMMI Phys . 2023 Sep; 10(1):58. PMID: 37736779
Background: The aim of this study was to investigate the quantification performance of a 360° CZT camera for Lu-based treatment monitoring. Methods: Three phantoms with known Lu activity concentrations were...
8.
Plachouris D, Eleftheriadis V, Nanos T, Papathanasiou N, Sarrut D, Papadimitroulas P, et al.
Med Phys . 2023 Sep; 50(11):7222-7235. PMID: 37722718
Background: Standardized patient-specific pretreatment dosimetry planning is mandatory in the modern era of nuclear molecular radiotherapy, which may eventually lead to improvements in the final therapeutic outcome. Only a comprehensive...
9.
Costea M, Zlate A, Serre A, Racadot S, Baudier T, Chabaud S, et al.
Radiother Oncol . 2023 Aug; 188:109870. PMID: 37634765
Purpose: To investigate the performance of 4 atlas-based (multi-ABAS) and 2 deep learning (DL) solutions for head-and-neck (HN) elective nodes (CTVn) automatic segmentation (AS) on CT images. Material And Methods:...
10.
Hemon C, Rigaud B, Barateau A, Tilquin F, Noblet V, Sarrut D, et al.
J Appl Clin Med Phys . 2023 May; 24(8):e13991. PMID: 37232048
Purpose: To evaluate deep learning (DL)-based deformable image registration (DIR) for dose accumulation during radiotherapy of prostate cancer patients. Methods And Materials: Data including 341 CBCTs (209 daily, 132 weekly)...